Submissions for variant NM_032043.3(BRIP1):c.1474-3T>C

gnomAD frequency: 0.00001  dbSNP: rs552752779

Total submissions: 14

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Ambry Genetics	RCV000164980	SCV000215673	likely benign	Hereditary cancer-predisposing syndrome	2020-08-31	criteria provided, single submitter	clinical testing	This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae	RCV001085989	SCV000255149	likely benign	Familial cancer of breast; Fanconi anemia complementation group J	2024-01-27	criteria provided, single submitter	clinical testing
Illumina Laboratory Services, Illumina	RCV000348888	SCV000404610	uncertain significance	Fanconi anemia complementation group J	2018-01-12	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx	RCV000430204	SCV000512417	benign	not specified	2015-09-21	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genetic Services Laboratory, University of Chicago	RCV000430204	SCV000593766	uncertain significance	not specified	2016-12-27	criteria provided, single submitter	clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000589721	SCV000699667	benign	not provided	2017-05-08	criteria provided, single submitter	clinical testing	Variant summary: The BRIP1 c.1474-3T>C variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing, though ESE finder predicts the variant may introduce an SF2/ASF ESE site at the locus. However, these predictions have yet to be confirmed by functional studies. This variant was found in the large control database ExAC in 33 of 120864 control chromosomes from all ethnicities, but was predominantly observed in the South Asian subpopulation at a frequency of 0.001879 (31/16496). This frequency is about 30 times the estimated maximal expected allele frequency of a pathogenic BRIP1 variant (0.0000625), strongly suggesting this is likely a benign polymorphism found primarily in the populations of South Asian origin. Multiple clinical diagnostic laboratories have conflicting classifications for this variant including uncertain significance (4x in ClinVar) and benign (1x in ClinVar). The variant of interest has not, to our knowledge, been reported in affected individuals via publications, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.
Counsyl	RCV000662494	SCV000785013	uncertain significance	Fanconi anemia complementation group J; Neoplasm of ovary	2017-03-14	criteria provided, single submitter	clinical testing
Color Diagnostics, LLC DBA Color Health	RCV000164980	SCV000902752	benign	Hereditary cancer-predisposing syndrome	2016-11-17	criteria provided, single submitter	clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano	RCV000589721	SCV002046872	benign	not provided	2021-04-07	criteria provided, single submitter	clinical testing
Sema4, Sema4	RCV000164980	SCV002531358	likely benign	Hereditary cancer-predisposing syndrome	2021-04-13	criteria provided, single submitter	curation
Myriad Genetics, Inc.	RCV003316033	SCV004019335	likely benign	Familial cancer of breast	2023-02-28	criteria provided, single submitter	clinical testing	This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing.
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital	RCV000430204	SCV004026889	likely benign	not specified	2023-08-15	criteria provided, single submitter	clinical testing
PreventionGenetics, part of Exact Sciences	RCV003895136	SCV004715928	likely benign	BRIP1-related condition	2023-09-29	criteria provided, single submitter	clinical testing	This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Department of Pathology and Laboratory Medicine, Sinai Health System	RCV000348888	SCV001550572	uncertain significance	Fanconi anemia complementation group J		no assertion criteria provided	clinical testing	The BRIP1 c.1474-3T>C variant was not identified in the literature nor was it identified in the Cosmic or Zhejiang University Database. The variant was identified in dbSNP (ID: rs552752779) “With Uncertain significance allele”, ClinVar (with conflicting interpretations of pathogenicity; submitters: benign by GeneDx and uncertain significance by Ambry Genetics, Invitae, Illumina Clinical Services Laboratory and Genetic Services Laboratory-University of Chicago), Clinvitae (4x), and in control databases in 51 (1 homozygous) of 246022 chromosomes at a frequency of 0.0002 (Genome Aggregation Consortium Feb 27, 2017). The variant was identified in the following populations: European Non-Finnish in 1 of 111556 chromosomes (frequency: 0.000009) and South Asian in 50 (1 homozygous) of 30762 chromosomes (frequency: 0.002). The c.1474-3T>C variant is located in the 3' splice region but does not affect the invariant -1 and -2 positions; however, position -3 is part of the splicing consensus sequence and variants involving these positions sometimes affect splicing. 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as uncertain significance.